WallStreetZenWallStreetZen

NASDAQ: ELTX
Elicio Therapeutics Inc Stock Ownership - Who owns Elicio Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Elicio Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yekaterina ChudnovskyDirector2025-03-053,500,573$5.81
$20.34MBuy
Peter DemuthChief Scientific Officer2024-12-16381$4.41
$1.68kBuy
Jay VenkatesanDirector2024-11-2650,000$0.01
$500.00Buy

1 of 1

ELTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELTX insiders and whales buy or sell their stock.

ELTX Shareholders

What type of owners hold Elicio Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky33.86%5,416,212$53.30MInsider
Eisaabc LLC17.13%2,740,978$26.97MInsider
Itzhak Goldberg10.55%1,687,986$16.61MInsider
Victor F. Ganzi6.12%978,698$9.63MInsider
Knoll Capital Management LLC3.94%630,915$6.21MInstitution
Vanguard Group Inc2.84%454,619$4.47MInstitution
Jay Venkatesan1.13%180,534$1.78MInsider
Geode Capital Management LLC0.76%120,831$1.19MInstitution
Gilbert S. Omenn0.50%80,326$790.41kInsider
Northern Trust Corp0.32%51,000$501.84kInstitution

1 of 3

ELTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELTX9.07%70.40%Net Buying
NVCT12.74%40.90%Net Buying
ACTU26.83%73.17%Net Buying
FBRX61.45%38.55%Net BuyingNet Selling
ALEC59.85%40.15%Net SellingNet Selling
View Top Biotech Stocks

Elicio Therapeutics Stock Ownership FAQ

Who owns Elicio Therapeutics?

Elicio Therapeutics (NASDAQ: ELTX) is owned by 9.07% institutional shareholders, 70.40% Elicio Therapeutics insiders, and 20.53% retail investors. Yekaterina Chudnovsky is the largest individual Elicio Therapeutics shareholder, owning 5.42M shares representing 33.86% of the company. Yekaterina Chudnovsky's Elicio Therapeutics shares are currently valued at $51.45M.

If you're new to stock investing, here's how to buy Elicio Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.